Rare disorder of the posterior segment of the eye Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Rare disorder of the posterior segment of the eye.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Retisert

Bausch & Lomb Pharmaceuticals, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Retisert

(Fluocinolone)Orphan drugstandard

Bausch & Lomb Pharmaceuticals, Inc.

Corticosteroid [EPC]

12.1 Mechanism of Action Corticosteroids inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They in...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare disorder of the posterior segment of the eye.
Search all trials →

Search clinical trials for Rare disorder of the posterior segment of the eye →

Recent News & Research

No recent news articles indexed yet for Rare disorder of the posterior segment of the eye.
Search PubMed for Rare disorder of the posterior segment of the eye →

Browse all Rare disorder of the posterior segment of the eye news →

Specialist Network

No specialists currently listed for Rare disorder of the posterior segment of the eye.

View all Rare disorder of the posterior segment of the eye specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰